Tapewire

Nasdaq · USD

ORMP

ORAMED PHARMACEUTICALS INC.

Export transactions ↓
Tapewire entity
6311
SEC CIK
0001176309
Parsed reports
201

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202602
Aug 202600
Sep 202600
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 02, 2022 Filed May 3, 2022 21:30 UTC
Rozov YadinDirector
GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $5.14 $0.00
Disclosure

SEC source: 0001213900-22-023728 · ownership.xml · derivative · entry 2

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-05-02

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 1,875 shall vest on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026.

Read SEC document
May 02, 2022 Filed May 3, 2022 21:30 UTC
Rozov YadinDirector
GrantCommon Stock 4,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-023728 · ownership.xml · nonDerivative · entry 1

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,125 shall vest on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 00:30 UTC
RAKIN KEVINDirector
SaleCommon Stock 10,000 $9.41 $94,096.00
Disclosure

SEC source: 0001213900-22-014283 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,661

Read SEC document
February 17, 2022 Filed Feb 22, 2022 22:30 UTC
RAKIN KEVINDirector
Exercise / conversionStock Option (right to buy) · Derivative 6,667 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-22-008755 · ownership.xml · derivative · entry 3

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,667 shares

Expires 2030-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 22:30 UTC
RAKIN KEVINDirector
Tax withholdingCommon Stock 3,010 $10.63 $31,996.30
Disclosure

SEC source: 0001213900-22-008755 · ownership.xml · nonDerivative · entry 2

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,661

F1 · shares: Represents a cashless exercise of outstanding stock options to purchase 6,667 shares of common stock. The reporting person received 3,657 shares of common stock and surrendered 3,010 shares of common stock underlying the stock option in payment of the exercise price.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 22:30 UTC
RAKIN KEVINDirector
Exercise / conversionCommon Stock 6,667 $4.80 $32,001.60
Disclosure

SEC source: 0001213900-22-008755 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,671

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2022 Filed Feb 14, 2022 22:30 UTC
RAKIN KEVINDirector
GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-007695 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,004

F1 · price: This transaction represents a charitable donation effective February 11, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 22:30 UTC Amendment
RAKIN KEVINDirector
GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-007951 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,004

F1 · price: This transaction represents a charitable donation effective February 11, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares.

F2 · balance_after: This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Rakin, which reported that 47,004 shares of common stock are beneficially owned by him following the reported transaction. Mr. Rakin beneficially owned 53,004 shares of common stock following the reported transaction.

Read SEC document
January 09, 2022 Filed Jan 12, 2022 01:40 UTC
Derovan NetanelChief Legal Officer
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.03 $0.00
Disclosure

SEC source: 0001213900-22-001617 · ownership.xml · derivative · entry 2

Derovan Netanel · CIK 0001901330 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 7,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 09, 2022 Filed Jan 12, 2022 01:40 UTC
Derovan NetanelChief Legal Officer
GrantCommon Stock 18,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-001617 · ownership.xml · nonDerivative · entry 1

Derovan Netanel · CIK 0001901330 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:52 UTC
Sank LeonardDirector
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000822 · ownership.xml · derivative · entry 3

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-01-03

F3 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:52 UTC
Sank LeonardDirector
GrantCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000822 · ownership.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:51 UTC
Mayer ArieDirector
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000820 · ownership.xml · derivative · entry 2

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:51 UTC
Mayer ArieDirector
GrantCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000820 · ownership.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:41 UTC
KIDRON NADAVDirector · President and CEO
GrantStock Option (right to buy · Derivative 107,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000818 · ownership.xml · derivative · entry 4

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,000

Underlying: Common Stock · 107,000 shares

Expires 2032-01-03

F4 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 26,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:41 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 63,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000818 · ownership.xml · nonDerivative · entry 3

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 950,729

F3 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 15,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:41 UTC
KIDRON NADAVDirector · President and CEO
Tax withholdingCommon Stock 48,752 $13.89 $677,165.28
Disclosure

SEC source: 0001213900-22-000818 · ownership.xml · nonDerivative · entry 2

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 887,729

F2 · shares: Payment of tax liability by withholding securities incident to the 150,000 shares of Common Stock granted on January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:41 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 150,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000818 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 936,481

F1 · price: Represents Common Stock granted by the Issuer that vested upon grant.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:39 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 72,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000816 · ownership.xml · derivative · entry 2

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,000

Underlying: Common Stock · 72,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 18,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:39 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 42,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000816 · ownership.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,666

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 10,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:38 UTC
Rabinowitz MichaelChief Commercial Officer
GrantStock Option (right to buy) · Derivative 32,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000814 · ownership.xml · derivative · entry 2

Rabinowitz Michael · CIK 0001767090 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 8,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:38 UTC
Rabinowitz MichaelChief Commercial Officer
GrantCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000814 · ownership.xml · nonDerivative · entry 1

Rabinowitz Michael · CIK 0001767090 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,468

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:33 UTC
Hexter JoshuaCOO & CBO
GrantStock Option (right to buy) · Derivative 36,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000807 · ownership.xml · derivative · entry 2

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 9,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:33 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 21,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000807 · ownership.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,333

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 5,250 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:35 UTC
RAKIN KEVINDirector
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000810 · ownership.xml · derivative · entry 2

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:35 UTC
RAKIN KEVINDirector
GrantCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000810 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,004

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:32 UTC
Silberman DavidChief Financial Officer
GrantStock Option (right to buy) · Derivative 32,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000805 · ownership.xml · derivative · entry 2

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2032-01-03

F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 8,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:32 UTC
Silberman DavidChief Financial Officer
GrantCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000805 · ownership.xml · nonDerivative · entry 1

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:30 UTC GiftStock Option (right to buy · Derivative 10,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000802 · ownership.xml · derivative · entry 4

Friedman Aviad · CIK 0001683729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2032-01-03

F2 · kind: These shares of common stock and stock options were transferred, for no consideration, to a trust with an independent trustee.

F3 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:30 UTC GrantStock Option (right to buy · Derivative 10,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-000802 · ownership.xml · derivative · entry 3

Friedman Aviad · CIK 0001683729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-01-03

F3 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:30 UTC GiftCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-000802 · ownership.xml · nonDerivative · entry 2

Friedman Aviad · CIK 0001683729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: These shares of common stock and stock options were transferred, for no consideration, to a trust with an independent trustee.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 01:30 UTC GrantCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-000802 · ownership.xml · nonDerivative · entry 1

Friedman Aviad · CIK 0001683729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 03, 2022 Filed Jan 12, 2022 01:30 UTC Amendment
KIDRON NADAVDirector · President and CEO
GrantStock Option (right to buy · Derivative 107,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001213900-22-001613 · ownership.xml · derivative · entry 4

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,000

Underlying: Common Stock · 107,000 shares

Expires 2032-01-03

F5 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 26,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Read SEC document
January 03, 2022 Filed Jan 12, 2022 01:30 UTC Amendment
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 63,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-001613 · ownership.xml · nonDerivative · entry 3

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 930,729

F3 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 15,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

F4 · balance_after: This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Kidron, which reported that 950,729 shares of common stock are beneficially owned by him following the reported transactions. Mr. Kidron beneficially owned 930,729 shares of common stock following the reported transactions.

Read SEC document
January 03, 2022 Filed Jan 12, 2022 01:30 UTC Amendment
KIDRON NADAVDirector · President and CEO
Tax withholdingCommon Stock 48,752 $13.89 $677,165.28
Disclosure

SEC source: 0001213900-22-001613 · ownership.xml · nonDerivative · entry 2

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 867,729

F2 · shares: Payment of tax liability by withholding securities incident to the 150,000 shares of Common Stock granted on January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 12, 2022 01:30 UTC Amendment
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 150,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-001613 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 916,481

F1 · price: Represents Common Stock granted by the Issuer that vested upon grant.

Read SEC document
January 03, 2022 Filed May 10, 2022 21:32 UTC Amendment
Mayer ArieDirector
GrantCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-025289 · ownership.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

F2 · balance_after: This amendment is being filed to correct an administrative error in the Form 4 filed by Dr. Mayer, which reported that 9,000 shares of common stock were beneficially owned by him following the reported transaction. Dr. Mayer beneficially owned 6,000 shares of common stock following the reported transaction.

Read SEC document
December 30, 2021 Filed Dec 31, 2021 02:31 UTC
KIDRON NADAVDirector · President and CEO
GiftCommon Stock 20,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-068231 · ownership.xml · nonDerivative · entry 2

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 766,481

F2 · price: This transaction represents a charitable donation effective December 30, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. The Reporting Person is not affiliated with, and has no control over, the donee.

Read SEC document
December 28, 2021 Filed Dec 31, 2021 02:31 UTC
KIDRON NADAVDirector · President and CEO
Tax withholdingCommon Stock 31,728 $12.98 $411,829.44
Disclosure

SEC source: 0001213900-21-068231 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 786,481

F1 · kind: Payment of tax liability by withholding securities incident to the vesting of the issued security.

Read SEC document
December 28, 2021 Filed Dec 31, 2021 02:30 UTC
Rabinowitz MichaelChief Commercial Officer
Tax withholdingCommon Stock 9,532 $12.98 $123,725.36
Disclosure

SEC source: 0001213900-21-068230 · ownership.xml · nonDerivative · entry 1

Rabinowitz Michael · CIK 0001767090 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,468

F1 · kind: Payment of tax liability by withholding securities incident to the vesting of the issued security.

Read SEC document
December 16, 2021 Filed Dec 17, 2021 22:15 UTC
RAKIN KEVINDirector
GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-066053 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,004

F1 · price: This transaction represents a charitable donation effective December 16, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 22:15 UTC
KIDRON NADAVDirector · President and CEO
GiftCommon Stock 20,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-063983 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 818,209

F1 · price: This transaction represents a charitable donation effective December 3, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. The Reporting Person is not affiliated with, and has no control over, the donee.

Read SEC document
November 01, 2021 Filed May 10, 2022 21:30 UTC
Mayer ArieDirector
SaleCommon Stock 3,000 $25.60 $76,800.00
Disclosure

SEC source: 0001213900-22-025288 · ownership.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 16, 2021 Filed Sep 20, 2021 20:01 UTC
RAKIN KEVINDirector
SaleCommon Stock 21,100 $20.99 $442,829.92
Disclosure

SEC source: 0001213900-21-048832 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,004

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:48 UTC
Silberman DavidChief Financial Officer
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $20.19 $0.00
Disclosure

SEC source: 0001213900-21-046413 · ownership.xml · derivative · entry 2

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-09-01

F3 · derivative.exercise_date: The Stock Options will vest in four equal installments of 12,500 on each of June 27, 2022, June 27, 2023, June 27, 2024 and June 27, 2025.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:48 UTC
Silberman DavidChief Financial Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-046413 · ownership.xml · nonDerivative · entry 1

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · security: Represents common stock underlying Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · date: The RSUs will vest as follows: 33,333 shall vest in three equal installments over a period of three years upon Issuer's common stock achieving a specified price per share, and 16,667 shall vest in three equal installments over a period of three years upon Issuer's achievement of certain business objectives.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:46 UTC
Hexter JoshuaChief Operating & BO
GrantCommon Stock 33,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-046410 · ownership.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · Chief Operating & BO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,333

F1 · price: Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:46 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 66,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-046411 · ownership.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,666

F1 · price: Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:44 UTC
RAKIN KEVINDirector
GrantCommon Stock 10,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-046408 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,104

F1 · price: Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:43 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-046407 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 748,573

F1 · price: Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.